About 81,000 Baby Monitors Recalled Over Possible Fire Risk
via HealthDayWEDNESDAY, March 4, 2026 — Parents who use baby monitors may want to take a closer look at the one they have at home.
The U.S. Consumer Product Safety Commission (CPSC) has announced a recall of about 81,000 babysense Max View Baby Monitors because the display unit can overheat and create a possible fire hazard.
The monitors are made by Hisense, which has received 11 reports of overheating incidents involving the handheld display unit. So far, no injuries have been reported.
The problem involves the display that parents use to see and hear their baby, not the physical camera placed in a child’s room.
The recall applies to monitors with the model number VBM55RX.
Parents can check the label on the back of the display to find the model number. The screen also shows “5.5 HD 1080P” in the upper left corner and the babysense logo at the bottom.
The recalled monitors were sold online through Amazon, Walmart and babylist from January 2023 through December 2025 for between $90 and $180.
Families who own one of the recalled monitors should stop using it immediately, the CPSC says.
Hisense is offering customers a free replacement display unit that does not overheat.
Parents can contact babysense by phone at 833- 689-2652 from 9 a.m. to 5 p.m. ET, Monday through Friday. They can also reach the company by email at [email protected]; or online at www.recallsecure.com or www.babysensemonitors.com and click on “Product Recalls” at the top of the page for more information.
It's important to note that officials urge parents not to throw the device in the trash or recycling.
The monitor contains a lithium-ion battery, which can catch fire if not disposed of properly.
Instead, folks should contact their local household hazardous waste collection center to learn the best way to discard the device.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-05 01:43
Read more
- EAU: Patient Satisfaction Improved With Virtual Reality to Explain Shock Wave Lithotripsy
- ACC: Shingles Vaccine May Lower Risk for MACE in Patients With Atherosclerotic CVD
- Novartis Remibrutinib First Therapy to Achieve Phase III Primary Endpoint in Chronic Inducible Urticaria (CIndU)
- FDA Approves Novo Nordisk's Sogroya as the First and Only Once-Weekly, Long-Acting Growth Hormone for Three Additional Pediatric Indications
- Recommendations Developed for Faltering Weight in Children
- New Lyme Disease Vaccine Shows Strong Results in Trial
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions